Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$226.5M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM MYPS
FY Dec 2025
$235.1M
FY Dec 2024
$289.4M
FY Dec 2023
$310.9M
FY Dec 2022
$290.3M
FY Dec 2021
$287.4M
Jun 2026
$55.0M
Mar 2026
$58.4M
Dec 2025
$55.4M
Sep 2025
$57.6M
Jun 2025
$59.3M
Mar 2025
$62.7M
Dec 2024
$67.8M
Sep 2024
$71.2M
At each fiscal year end
Single quarter
Net margin, TTM
-20.6%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM MYPS
FY Dec 2025
-12.2%
FY Dec 2024
-9.9%
FY Dec 2023
-6.2%
FY Dec 2022
-6.1%
FY Dec 2021
+3.7%
Jun 2026
-24.1%
Mar 2026
-18.3%
Dec 2025
-24.7%
Sep 2025
-15.8%
Jun 2025
-5.0%
Mar 2025
-4.6%
Dec 2024
-33.1%
Sep 2024
-4.3%
At each fiscal year end
Single quarter
Free cash flow, TTM
$18.0M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM MYPS
FY Dec 2025
$25.4M
FY Dec 2024
$41.8M
FY Dec 2023
$45.4M
FY Dec 2022
$21.4M
FY Dec 2021
$31.9M
Jun 2026
$5.4M
Mar 2026
$3.7M
Dec 2025
$3.6M
Sep 2025
$5.4M
Jun 2025
$13.2M
Mar 2025
$3.2M
Dec 2024
$11.5M
Sep 2024
$13.9M
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity MYPS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt MYPS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-20.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity MYPS
FY Dec 2025
-12.1%
FY Dec 2024
-10.8%
FY Dec 2023
-6.6%
FY Dec 2022
-5.9%
FY Dec 2021
+5.4%
Jun 2026
-20.6%
Mar 2026
-15.7%
Dec 2025
-12.1%
Sep 2025
-14.8%
Jun 2025
-12.3%
Mar 2025
-11.6%
Dec 2024
-10.8%
Sep 2024
-9.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-15.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets MYPS
FY Dec 2025
-9.3%
FY Dec 2024
-8.3%
FY Dec 2023
-5.4%
FY Dec 2022
-5.2%
FY Dec 2021
+4.6%
Jun 2026
-15.9%
Mar 2026
-12.2%
Dec 2025
-9.3%
Sep 2025
-11.9%
Jun 2025
-9.6%
Mar 2025
-9.2%
Dec 2024
-8.3%
Sep 2024
-7.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital MYPS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-16.1%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed MYPS
FY Dec 2025
-9.2%
FY Dec 2024
-11.1%
FY Dec 2023
-3.3%
FY Dec 2022
-9.0%
FY Dec 2021
-1.5%
Jun 2026
-16.1%
Mar 2026
-13.5%
Dec 2025
-9.2%
Sep 2025
-13.1%
Jun 2025
-11.7%
Mar 2025
-11.4%
Dec 2024
-11.1%
Sep 2024
-4.3%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing MYPS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
56.43x
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no share count filed
Enterprise value MYPS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
no share count filed
FCF yield MYPS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing MYPS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
MYPS ranks highest on institutional and government (36th percentile) and profitability (33rd), and lowest on growth (14th), among Software & IT peers.
Profitability
33
Inputs
Return on equity-20.6% · 31 pct, sector of 286
Return on assets-15.9% · 35 pct, sector of 381
Return on invested capitalpre-tax loss, no effective tax rate to apply
Return on capital employed-16.1% · 31 pct, sector of 294
Growth
14
Inputs
Revenue growth, YoY-18.8% · 14 pct, sector of 480
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
36
Inputs
Funds adding, latest quarter50 · 36 pct, sector of 415
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
26
Inputs
Short interest, % of float+5.3% · 46 pct, sector of 530
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+45.2% · 6 pct, sector of 316
3 not measured: Financial health, Insider conviction, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.